Iain Dukes

Iain Dukes is recorded as Board Member at Traws Pharma, Inc. (TRAW) since April 1, 2024 and CEO at Traws Pharma, Inc. (TRAW). The newest filing on record that lists Iain Dukes as CEO and Board Member at Traws Pharma, Inc. (TRAW) is dated May 29, 2026. Traws Pharma, Inc. reported in an 8-K filed March 28, 2025 that Iain Dukes was appointed Interim Chief Executive Officer, effective March 31, 2025. Traws Pharma, Inc. reported in an 8-K filed April 4, 2024 that Iain Dukes was appointed director, effective April 1, 2024. Traws Pharma, Inc. reported in an 8-K filed April 4, 2024 that Iain Dukes was appointed Executive Chairman, effective April 1, 2024. The proxy statement of Traws Pharma, Inc. reports total compensation of $1,401,924 for Iain Dukes in fiscal 2025, including a base salary of $539,000. Traws Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Traws Pharma, Inc. includes Iain D. Dukes (CEO and Board Member), Werner Cautreels (CEO and Board Member), Jack E. Stover (Chairman) and 7 others.